Edwards Lifesciences EW Payment for working capital adjustment for sale of product group
Payment for working capital adjustment for sale of product group at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept ew:DisposalGroupPaymentForWorkingCapitalAdjustment.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's payment for working capital adjustment for sale of product group.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's payment for working capital adjustment for sale of product group?
- Edwards Lifesciences (EW) reported payment for working capital adjustment for sale of product group of $0 in Q1 2026.
- How has Edwards Lifesciences's payment for working capital adjustment for sale of product group changed year-over-year?
- Edwards Lifesciences's payment for working capital adjustment for sale of product group decreased by 100.0% year-over-year, from $36.3M to $0.
- What does payment for working capital adjustment for sale of product group mean?
- Cash adjustments paid to a buyer following the divestiture of a business unit to reconcile working capital differences at the time of closing. This reflects the final financial settlement of a divestment transaction.